Page last updated: 2024-10-17

phloroglucinol and Somatoform Disorders

phloroglucinol has been researched along with Somatoform Disorders in 1 studies

Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.

Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)

Research Excerpts

ExcerptRelevanceReference
"The recent clinical studies on hypericum extract support the present indications for its use in mild to moderate depression and depressive episodes."4.84[New developments in hypericum extracts: data on efficacy and interactions]. ( Kraft, K, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kraft, K1

Reviews

1 review available for phloroglucinol and Somatoform Disorders

ArticleYear
[New developments in hypericum extracts: data on efficacy and interactions].
    Wiener medizinische Wochenschrift (1946), 2007, Volume: 157, Issue:13-14

    Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bridg

2007